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Abstract
Background: Oviduct epithelial cells (OEC) co-culture promotes in vitro fertilization (IVF) in
human, bovine and porcine species, but no data are available from equine species. Yet, despite
numerous attempts, equine IVF rates remain low. Our first aim was to verify a beneficial effect of
the OEC on equine IVF. In mammals, oviductal proteins have been shown to interact with gametes
and play a role in fertilization. Thus, our second aim was to identify the proteins involved in
fertilization in the horse.
Methods & results: In the first experiment, we co-incubated fresh equine spermatozoa treated
with calcium ionophore and in vitro matured equine oocytes with or without porcine OEC. We
showed that the presence of OEC increases the IVF rates. In the subsequent experiments, we co-
incubated equine gametes with OEC and we showed that the IVF rates were not significantly
different between 1) gametes co-incubated with equine vs porcine OEC, 2) intact cumulus-oocyte
complexes  vs  denuded oocytes, 3) OEC previously stimulated with human Chorionic
Gonadotropin, Luteinizing Hormone and/or oestradiol vs non stimulated OEC, 4) in vivo vs in vitro
matured oocytes.
In order to identify the proteins responsible for the positive effect of OEC, we first searched for
the presence of the genes encoding oviductin, osteopontin and atrial natriuretic peptide A (ANP
A) in the equine genome. We showed that the genes coding for osteopontin and ANP A are
present. But the one for oviductin either has become a pseudogene during evolution of horse
genome or has been not well annotated in horse genome sequence. We then showed that
osteopontin and ANP A proteins are present in the equine oviduct using a surface plasmon
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resonance biosensor, and we analyzed their expression during oestrus cycle by Western blot.
Finally, we co-incubated equine gametes with or without purified osteopontin or synthesized ANP
A. No significant effect of osteopontin or ANP A was observed, though osteopontin slightly
increased the IVF rates.
Conclusion: Our study shows a beneficial effect of homologous and heterologous oviduct cells
on equine IVF rates, though the rates remain low. Furthers studies are necessary to identify the
proteins involved. We showed that the surface plasmon resonance technique is efficient and
powerful to analyze molecular interactions during fertilization.
Background
The oviduct is an essential organ in reproductive biology.
This organ supports gamete transport, maturation, capac-
itation, fertilization, early embryonic growth and embryo
transport to the uterus [1]. Oviduct fluid is comprised of a
serum filtrate, follicular fluid and oviduct-specific secre-
tory products from secretory cells [2]. The secretion of ovi-
duct secretory cells increases during the follicular phase
under oestrogen and LH stimulation [3,4]. Some studies
show that oviduct epithelial cells (OEC) co-culture pro-
motes in vitro production of embryos in human [5,6],
bovine[7-9], porcine [10,11], deer [12,13] and dromedary
[14]. Moreover, the oviduct proteins have been shown to
interact with gametes and to improve efficiency of in vitro
fertilization (IVF) in porcine [10,15], bovine [9] and
human [16]. Some of these proteins have been identified:
osteopontin [17-19] in bovine and porcine, Atrial Natriu-
retic Peptide A (ANP A), [20-22] and oviductin [[9,23] for
review;[10]] in bovine, porcine and human.
In the equine, numerous attempts to establish an efficient
IVF technique were performed during the last decades [24-
27]. However, reported fertilization rates range from 0%
to 60% which are lower than the IVF rates of 90 to 95%
observed in porcine [[28,29] for review, [30] for review,
[31] for review], bovine [[32] for review], caprine [33-36]
or ovine species [37,38]. No repeatable equine IVF tech-
nique is available yet. In equine species, the co-culture
with OEC improves the capacitation of spermatozoa eval-
uated by chlortetracycline staining and zona binding
[39,40] or intracellular calcium concentration and acro-
some reaction [41,42]. It also improves the selection of
spermatozoa determined by the percentage of motile and
morphologically normal spermatozoa attached to oviduc-
tal cells [43,44]. The in vivo fertilization of in vitro matured
oocytes in the oviduct of mare predicts an influence of
oviduct in the equine fertilization [45-47]. However, IVF
in co-culture with OEC has never been investigated in this
species. In addition, the role of oviductal secretion on the
equine fertilization is unknown.
We hypothesized that the secretion of oviduct cells could
improve equine IVF. The aims of our study were 1) to ver-
ify the beneficial effect of the oviduct cells and fluid on
equine IVF, and 2) to identify the proteins responsible for
this positive effect.
Methods
All chemicals were purchased from Sigma-Aldrich (St
Quentin Fallavier, France) unless otherwise indicated. All
procedures described within were approved by the "Insti-
tut National de la Recherche Agronomique" Animal Care
and Use Committee, and were performed in accordance
with the Guiding Principles for the Care and Use of Labo-
ratory Animals.
General methods
Preparation of equine and porcine oviduct epithelial vesicles and 
monolayers
Porcine oviducts were collected from slaughtered Meishan
gilts from our experimental pigsty (UE1297 Unité Expéri-
mentale de Physiologie Animale de l'Orfrasière, Nouzilly,
France). Adult cyclic gilts received a daily dose of 5 ml
Regumate (20 mg/gilt/day of Altrenogest, Intervet S.A.,
Angers, France) per os during 18 days. An intravenous
injection of human Chorionic Gonadotropin (hCG, Cho-
rulon®, 500 IU/gilt, Intervet S.A.) was performed 3 days
later. Gilts were slaughtered 46 hours after hCG injection
(6 hours after ovulation) and the two oviducts were
immediately collected.
Equine oviducts ipsilateral to ovulation were collected
from slaughtered adult cyclic Welsh pony mares from our
experimental stud (UE1297 Unité Expérimentale de Phys-
iologie Animale de l'Orfrasière, Nouzilly). Ovarian activ-
ity was assessed by routine rectal ultrasound scanning. An
intravenous injection of 15 mg of Crude Equine Gonado-
tropin (CEG, [48]) was performed at the end of the follic-
ular phase, when the largest follicle reached 33 mm in
diameter, to induce ovulation. Then, ovarian activity was
assessed every two hours from 32 hours post induction to
ovulation. Mares were slaughtered 6 hours after ovulation
and the oviduct ipsilateral was immediately collected.
Equine and porcine oviducts were transported to the lab-
oratory within a few minutes in Tissue Culture Medium
199 with Hepes and Earls's salts (TCM199-Hepes) with 80
μg ml-1 gentamycin at 37°C.Reproductive Biology and Endocrinology 2009, 7:129 http://www.rbej.com/content/7/1/129
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The equine or porcine oviduct epithelial cells were pre-
pared according to Locatelli et al. [13]. The oviducts were
dissected free from surrounding tissues and washed. The
oviduct fluid and epithelial cells were expelled by gentle
squeezing using a sterile microscope slide in a Petri dish.
Resulting epithelium fragments were washed three times
in TCM199-Hepes with 80 μg ml-1 gentamycin. These frag-
ments formed vesicles which were cultured in culture
medium containing Tissue Culture Medium 199 with
Earls's salts (TCM199) with 10% (v/v) Fetal Calf Serum
(FCS) and 40 μg ml-1 gentamycin in an incubator (at
38.5°C in an atmosphere of 5% CO2 in air in 100%
humidity). Vesicles were cultured either for 24 hours in 35
μl drops of culture medium covered with 500 μl mineral
oil or for 7 days in 500 μl of culture medium with renewal
of the culture medium every 48 hours. After 7 days, only
confluent cell monolayers containing epithelial cells and
cells with ciliary activity, free of fibroblasts (elongated
cells) and bacteria, were used for the experiments.
Preparation of equine in vitro matured oocytes
Equine immature cumulus-oocyte complexes (COCs)
were collected from slaughtered mares. Ovaries were
obtained in local slaughterhouses immediately after
females were killed and transported to the laboratory
within 2 hours in 0.9% (w/v) NaCl at 32-38°C. COCs
were collected with the aspiration procedure as previously
described by Mugnier et al. [49]. Immature COCs were
washed once in washing medium containing TCM199-
Hepes supplemented with 40 μg ml-1 Bovine Serum Albu-
min (BSA, fatty acid free) and 25 μg ml-1 gentamycin and
once in maturation medium containing TCM199 supple-
mented with 20% (v/v) FCS and 50 ng ml-1 epidermal
growth factor [50]. COCs were cultured in groups of 10 to
25 oocytes for 26 to 30 hours in 500 μl of maturation
medium in an incubator. After in vitro maturation (IVM),
only oocytes showing an intact oolemma were kept.
Recovery of equine in vivo matured oocytes
Equine in vivo matured COCs were collected by transvagi-
nal ultrasound-guided aspiration in standing mares from
our experimental stud as previously described by Mugnier
et al. [51].
Preparation of equine semen
Semen was collected from two Welsh pony stallions (A
and B) from our experimental stud using an artificial
vagina. Sperm cells from each stallion were prepared sep-
arately as previously described by Palmer et al. [24].
Briefly, sperm was collected, filtered, diluted to 25 × 106
spermatozoa ml-1 in Hank's solution supplemented with
1% (w/v) BSA and 20 mmol l-1 Hepes (HHBSA) at pH 7.1,
and incubated at 37°C for 30 minutes in anaerobic con-
ditions. Spermatozoa were then treated with 6 μmol l-1 of
calcium ionophore A23187 (free acid) at 37°C for 5 min-
utes [52], centrifuged for 3 minutes at 500 × g and resus-
pended in HHBSA medium (25 × 106 spermatozoa ml-1).
The motility was visually evaluated using an inverted epi-
fluorescence microscope (Olympus, IMT-2, Paris, France).
Assessment of equine in vitro fertilization (IVF) rates
After 24 hours of male and female gametes co-incubation,
oocytes were washed by aspiration in and out of a glass
pipette in Dulbecco's Phosphate Buffered Saline solution
(DPBS, Dulbecco A, Paris, France) to remove spermatozoa
attached to the zona pellucida. Oocytes were fixed in 2%
(v/v) paraformaldehyde in DPBS overnight at 4°C,
stained by 2.5 μmol l-1 bisbenzimide (Hoechst 33258) in
DPBS:Glycerol (3:1, v/v), mounted on microscope slides,
and observed under an inverted epifluorescence micro-
scope. Normal fertilization was defined by the presence of
two polar bodies and two pronuclei. The IVF rate was cal-
culated as the ratio of fertilized oocytes out of mature
oocytes (oocytes in metaphase II, activated and fertilized
oocytes) as previously described by Mugnier et al. [51].
Statistical analysis
For each experiment, due to the limited number of
oocytes available on a single day, two to three replicates
were performed. The IVF rates were compared between
groups of oocytes in each experiment using chi-square
analysis. When the number of oocytes in a group was too
low for the chi-square test, the Fisher's exact test was used.
Differences were considered statistically significant at P ≤
0.05.
Experiment 1: Influence of porcine vesicles and cell 
monolayers on equine IVF
We tested the influence of porcine vesicles in the first trial
(three replicates) and the influence of porcine cell monol-
ayers in the second trial (two replicates).
After in vitro maturation, all equine COCs were mechani-
cally denuded in 500 μl washing medium and washed in
culture medium. Oocytes (10 to 20 per group) were co-
incubated with or without vesicles or cell monolayers,
depending on the trial, for 2 to 3 hours in an incubator.
Spermatozoa (final concentration of 2.5 × 106 cells ml-1)
from stallion A or B were added with oocytes. Gametes
were co-incubated in a final volume of 50 μl in the first
trial and 515 μl in the second trial, for 24 hours in an incu-
bator.
Experiment 2: Influence of equine vs porcine vesicles and 
cell monolayers on equine IVF
After in vitro maturation, all equine COCs were denuded
and washed. Oocytes (10 to 20 per group) were co-incu-Reproductive Biology and Endocrinology 2009, 7:129 http://www.rbej.com/content/7/1/129
Page 4 of 16
(page number not for citation purposes)
bated with equine or porcine vesicles or with equine or
porcine cell monolayers for 2 to 3 hours in an incubator.
Spermatozoa (final concentration of 2.5 × 106 cells ml-1)
from stallion A or B were added with oocytes. Gametes
were co-incubated in a final volume of 50 μl with porcine
or equine vesicles or 515 μl with porcine or equine cell
monolayers, for 24 hours in an incubator. This experi-
ment was repeated once with equine vesicles (stallion A),
four times with equine cell monolayers (twice with stal-
lion A and twice with stallion B), five times with porcine
vesicles and cell monolayers (twice with stallion A and
three times with stallion B).
Experiment 3: Influence of equine cumulus cells on equine 
IVF
After in vitro maturation, half of the COCs were mechani-
cally denuded in the washing medium and half were kept
intact.
Denuded oocytes or COCs (10 to 20 per group) were
rinsed in the culture medium and co-incubated with por-
cine vesicles for 2 to 3 hours in an incubator.
Spermatozoa (final concentration of 2.5 × 106 cells ml-1)
were added with COCs or denuded oocytes. Gametes were
co-incubated in a final volume of 50 μl for 24 hours in an
incubator. This experiment was repeated once with stal-
lion A and once with stallion B.
Experiment 4: Influence of hormonal stimulation of 
porcine oviduct cells on equine IVF
We compared the IVF rates after co-incubation of equine
gametes with porcine vesicles or cell monolayers stimu-
lated or not by hormones. Eight trials were performed:
vesicles and cell monolayers were stimulated with Lutein-
izing Hormone (LH), human Chorionic Gonadotropin
(hCG), Estradiol-17 beta (E2) or LH and E2. Each trial was
repeated once with stallion A and once with stallion B.
The hormones used were: 1) 0.1 μg ml-1 of porcine LH
(kindly donated by J-F Beckers, University of Liege, Bel-
gium), 2) 150 mIU ml-1 of hCG, 3) 1 μg ml-1 Estradiol-17
beta (E2) or 4) the association of LH (0.1 μg ml-1) and E2
(1  μg ml-1). The hormones were added to the culture
medium of the oviduct cells 24 hours before gametes co-
incubation.
In each trial, after in vitro maturation, all equine COCs
were denuded and washed. Oocytes (10 to 20 per group)
were co-incubated for 2 to 3 hours with oviduct cells stim-
ulated or not in an incubator. Spermatozoa (final concen-
tration of 2.5 × 106 cells ml-1) from stallion A or B were
added with oocytes. Gametes were co-incubated in a final
volume of 50 μl with porcine vesicles or 515 μl with por-
cine cell monolayers, for 24 hours in an incubator.
Experiment 5: Influence of porcine oviduct cells on equine 
IVF of in vivo matured oocytes
After the recovery of in vivo matured oocytes, some COCs
were mechanically denuded in the washing medium and
some were kept intact. In the first trial, intact COCs were
rinsed once in culture medium and co-incubated individ-
ually with or without porcine vesicles. In the second trial,
intact COCs and denuded oocytes were rinsed once in cul-
ture medium and co-incubated individually with or with-
out porcine cell monolayers.
COCs or denuded oocytes were co-incubated with or
without porcine oviduct cells for 2 to 3 hours in an incu-
bator. Spermatozoa (final concentration of 2.5 × 106 cells
ml-1) from stallion A or stallion B were added with
denuded oocytes or COCs. Gametes were co-incubated in
a final volume of 50 μl in the first trial or 515 μl in the sec-
ond trial, for 24 hours in an incubator.
During follicular punctures, immature equine COCs were
also collected from small follicles as previously described
[53] to compare in vivo and  in vitro matured oocytes.
Immature COCs were cultured in the maturation medium
for 26 to 30 hours as described in "General methods" sec-
tion. After in vitro maturation, all equine COCs were
denuded, rinsed and co-incubated for 2 to 3 hours with
cell monolayers in an incubator. Spermatozoa (final con-
centration of 2.5 × 106 cells ml-1) from stallion A or stal-
lion B were added with denuded in vitro matured oocytes.
Gametes were co-incubated in a final volume of 515 μl
with or without monolayer cells for 24 hours in an incu-
bator.
Experiment 6: Identification of oviductin, osteopontin and 
ANP A genes and proteins in equine species
Identification of genes in the equine genome
In NCBI and Ensembl databases (http://
www.ncbi.nlm.nih.gov/projects/genome/guide/horse/,
http://www.ensembl.org/Equus_caballus/Info/Index,
[54]), we searched for the presence of OVGP1 gene encod-
ing oviductin, SPP1 gene encoding osteopontin and NPPA
gene encoding ANP A in the equine genome.
To check the truthfulness of database annotation, we
computed tblastn [55] between amino acid sequence of
bovine oviductin [RefSeq: NP_001073685], osteopontin
[RefSeq: NP_776612] or ANP A [RefSeq: NP_776549] ver-
sus equin genome. Tblastn takes a protein query sequence
and compares it against a nucleotide database which has
been translated in all six reading frames. This program is
useful to reveal the presence of stop codon and/or inser-
tion/deletion in the nucleotide sequences. To focus on
comparing DNA sequences at the level of its conceptual
translation, regardless of sequencing error and introns, we
used genewise [56]. Genewise compares a proteinReproductive Biology and Endocrinology 2009, 7:129 http://www.rbej.com/content/7/1/129
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sequence to a genomic DNA sequence, allowing for
introns and frameshifting errors.
The evolutionary distances between equine oviductin,
osteopontin and ANP A and orthologue proteins from
pig, human, mouse or cow were computed by MEGA4
[57,58]. This program uses protein sequences to compute
an evolutionary distance matrix between every pair of
sequences in a multiple sequence alignment, under four
different models of amino acid replacement. Analyses
were conducted using the Jones-Taylor-Thornton matrix-
based method in MEGA4 model. The Jones-Taylor-Thorn-
ton model is similar to the Dayhoff PAM model, except
that it is based on a recounting of the number of observed
changes in amino acids and it uses a much larger sample
of protein sequences than did Dayhoff. The distance is
scaled in units of the expected fraction of amino acids
changed (100 PAM's). Because its sample is so much
larger this model is to be preferred over the original Day-
hoff PAM model.
Identification of proteins in the equine oviduct fluid using surface 
plasmon resonance
In order to analyze whether osteopontin and ANP A are
expressed in the equine oviduct, we used a surface plas-
mon resonance biosensor.
Equine oviducts were collected from slaughtered mares of
unknown oestrus cycle stage in commercial slaughter-
houses. Both oviducts were obtained immediately after
mare were killed and transported dry to the laboratory
within 2 hours. Oviducts were dissected free from sur-
rounding tissues. The oviduct fluid and epithelial cells
were expelled by gentle squeezing using a sterile micro-
scope slide on a Petri dish and stored at -20°C. Before use,
samples were centrifuged twice at 15000 × g for 15 min-
utes at 4°C.
Surface plasmon resonance experiments were performed
on BIAcore T100 (GE Healthcare). The antibodies (anti-
human osteopontin, R&D systems, Lille, France, and anti-
human ANP A) were immobilized on a CM5 sensor chip
(GE Healthcare), using standard amine coupling accord-
ing to the manufacturer's instructions. Anti-human oste-
opontin antibody and anti-human ANP A antibody were
immobilized at, respectively, 10500 resonance units (RU)
and 14000 RU. BSA and rabbit serum immunoglobulins
were used for reference surfaces and were immobilized at
similar levels. Binding analyses were carried out at 25°C
and a flow rate of 30 μl min-1. The centrifuged oviduct flu-
ids were diluted in the running buffer (10 mmol l-1 Hepes,
150 mmol l-1 NaCl, 0.05% (v/v) Tween 20 supplemented
with 1 g l-1 BSA). They were injected for 120 seconds. Dis-
sociation was studied during 120 seconds. Regeneration
of the surfaces was performed with 100 mmol l-1 H3PO4
for 30 seconds.
Expression of osteopontin and ANP A during the oestrus cycle in the 
equine oviduct fluid
In order to analyze the expression of osteopontin and
ANP A during the oestrus cycle, equine oviducts were col-
lected from slaughtered cyclic Welsh pony mares from our
experimental stud. Ovarian activity was assessed and
induction of ovulation was performed as described in
"General methods" section. Mares were slaughtered either
when the largest follicle reached 22 to 25 mm (emergence
of the dominant follicle, stage 1), when the largest follicle
reached 35 to 36 mm (end of the follicular growth, stage
2), or 34 hours after induction of ovulation, just before
ovulation (preovulatory stage, stage 3). Oviducts ipsilat-
eral were obtained immediately after mare were killed and
transported dry to the laboratory within a few minutes.
Oviducts were dissected free from surrounding tissues.
The oviduct fluid and epithelial cells were expelled, stored
and centrifuged as described above. The protein concen-
tration was evaluated in each sample using the Coomassie
prot assay reagent (Pierce, Thermo Fisher Scientific,
Brebières, France). Samples were diluted in electrophore-
sis Laemmli buffer (0.062 mol l-1 Tris-HCl pH 6.8, 5% (v/
v) glycerol, 1% (w/v) sodium dodecylsulfate, 0.5% (w/v)
blue-bromophenol, 2% (v/v) 2-betamercaptoethanol at
final concentration) and boiled at 95°C for 3 minutes.
Proteins were separated using 12% sodium dodecylsulfate
polyacrylamide gel electrophoresis (SDS-PAGE). Acryla-
mide - bisacrylamide solution was purchased from Serva
Electrophoresis GmbH (Heidelberg, Germany). For each
sample, 50 μg of total proteins were loaded on the gel. The
proteins were then transferred onto a polyvinylidene dif-
luoride membrane (hybond-P PVDF membrane transfert;
Amersham Pharmacia Biotech, Orsay, France) for 2 hours.
The membrane was washed with TBS (1.21 g l-1 Tris Base,
9 g l-1 NaCl, pH 7.4) containing 0.1% (v/v) Tween-20
(TBS-T), incubated overnight in blocking solution (5%
(w/v) non-fat dry milk, 0.2% (v/v) IGEPAL®, pH 7.4 in
TBS), and incubated for 3 hours with the primary antibod-
ies (anti-human osteopontin or anti-human ANP A)
diluted 1/500 in TBS-T. The membrane was washed with
TBS-T, incubated for 1 hour in blocking solution, incu-
bated for 1 hour with peroxidase-conjugated secondary
antibodies (mouse anti-goat IgG, Jackson ImmunoRe-
search Laboratories, Newmarket, United Kingdom)
diluted 1/2000 in blocking solution and washed with
TBS-T. The peroxydase activity was revealed using the
ECL-Plus Western blotting detection system (Amersham
Pharmacia Biotech). Two blots were performed for each
condition.
Checking for a potential expression of oviductin in the equine oviduct
To check the hypothesis that OVGP1 has become a pseu-
dogene in horse genome, and consequently that oviductinReproductive Biology and Endocrinology 2009, 7:129 http://www.rbej.com/content/7/1/129
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is not translated, we checked the presence of oviductin in
the equine oviduct. For this purpose, equine oviduct fluid
and cells were prepared as previously described and pro-
teins were submitted to the Western blot technique
described above, except that the primary antibody was
anti-bovine OGP (kindly donated by P.A. Mavrogianis at
University of Illinois in USA [59]) and the secondary anti-
body was goat anti-rabbit IgG (Eurobio, Courtaboeuf,
France).
Experiment 7: Influence of osteopontin and ANP A on 
equine IVF
After in vitro maturation, all equine COCs were denuded
and washed. Oocytes (10 to 20 per group) were co-incu-
bated with or without purified osteopontin from bovine
milk or synthesized human ANP A for 2 to 3 hours in a
final volume of 45 μl of culture medium covered with 500
μl of mineral oil in an incubator. Five trials were per-
formed: 1) osteopontin at final concentration of 0, 0.01 or
1 μg ml-1 [17], 2) osteopontin at final concentration of 0,
0.1 or 10 μg ml-1 [17,19], 3) osteopontin at final concen-
tration of 0, 50 or 100 μg ml-1 [18], 4) ANP A at final con-
centration of 0, 1 or 10 nmol l-1 [22], 5) ANP A at final
concentration of 0, 0.1 or 50 nmol l-1. Each trial was
repeated twice (once with stallion A and once with stal-
lion B).
Spermatozoa (final concentration of 2.5 × 106 cells ml-1)
from stallion A or stallion B were added with oocytes.
Influence of oviduct cells and/or cumulus cells on equine IVF Figure 1
Influence of oviduct cells and/or cumulus cells on equine IVF. A) In vitro fertilization rates (IVF, percentage of fertilized 
oocytes per matured oocytes) of equine gametes co-incubated with or without porcine vesicles; the IVF rates in the two 
groups are significantly different (*: P ≤ 0.05); B) Equine and porcine cell monolayers observed by microscopy at magnification 
×400. C) IVF rates of equine gametes co-incubated with equine or porcine vesicles or cell monolayers; the IVF rates in the four 
groups are not significantly different (P > 0.05); D) IVF rates of denuded oocytes or cumulus-oocyte complexes (COCs) in the 
presence of porcine vesicles; the IVF rates in the two groups are not significantly different (P > 0.05). The fractions represent 
the number of fertilized oocytes out of matured oocytes (oocytes in metaphase II, activated and fertilized).
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Gametes were co-incubated for 24 hours in a final volume
of 50 μl in an incubator.
Results
In each experiment, no significant difference in in vitro fer-
tilization (IVF) rates was observed between stallion A and
stallion B.
Experiment 1: Influence of porcine vesicles and cell 
monolayers on equine IVF
In the first trial, the co-incubation of equine gametes with
porcine vesicles significantly increased the IVF rates com-
pared to the co-incubation of equine gametes without ves-
icles (9% vs 0% respectively, P ≤ 0.05; Figure 1A). In the
second trial, equine oocytes incubated with (n = 21) or
without (n = 27) porcine cell monolayers were not ferti-
lized.
Experiment 2: Influence of equine vs porcine vesicles and 
cell monolayers on equine IVF
Figure 1B shows the cell monolayers from equine or por-
cine oviduct epithelial cells after 7 days of culture. The
equine IVF rates were not significantly different between
gametes co-culture with equine and porcine vesicles or
cell monolayers (P > 0.05; Figure 1C).
Experiment 3: Influence of equine cumulus cells on equine 
IVF
In experiment 3, equine gametes were co-incubated with
porcine vesicles. The IVF rates were not significantly differ-
ent between equine COCs and denuded oocytes (P > 0.05;
Figure 1D).
Experiment 4: Influence of hormonal stimulation of 
porcine oviduct cells on equine IVF
In experiment 4, equine gametes were co-incubated with
oviduct epithelial cells (vesicles or cell monolayers) stim-
ulated or not with LH, hCG or E2. The equine IVF rates
were not significantly different between stimulated and
not stimulated oviduct cells (P > 0.05; Figure 2). Moreo-
ver, when gametes were co-incubated with oviduct cells
co-stimulated with LH and E2, the equine IVF rate was
slightly higher than with non stimulated oviduct cells, but
the difference is not significant (P > 0.05; Figure 2).
Experiment 5: Influence of porcine oviduct cells on equine 
IVF of in vivo matured oocytes
In the first trial, 6 and 4 in vivo matured intact COCs were
co-incubated with or without porcine vesicles respec-
tively. No fertilization was observed after gametes co-
incubation with or without vesicles.
Influence of hormonal stimulation of oviduct cells on equine IVF Figure 2
Influence of hormonal stimulation of oviduct cells on equine IVF. In vitro fertilization rates (IVF, percentage of ferti-
lized oocytes per matured oocytes) of equine gametes co-incubated with vesicles or cell monolayers (CM) previously stimu-
lated or not with porcine Luteinizing Hormone (LH), human Chorionic Gonadotropin (hCG), Estradiol-17 beta (E2) or LH + 
E2. No significant statistical difference was observed (P > 0.05). The fractions represent the number of fertilized oocytes out of 
matured oocytes (oocytes in metaphase II, activated and fertilized).
vesicles
LH (μg ml-1)               0       0.1       0        0.1                   0       0.1        0       0.1 
hCG (mIU ml-1)                                                    0       150 0     150
E2 (μg ml-1)                                                                0        1         0       1         0         1
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In the second trial, 5 in vivo matured intact COCs and 5 in
vivo matured denuded oocytes were co-incubated with cell
monolayers and 5 in vivo matured intact COCs without
cell monolayers. No fertilization of COCs or denuded
oocytes was observed after gametes co-incubation with or
without cell monolayers.
At the same time, 6% of equine in vitro matured oocytes
(n = 15) were fertilized after their co-incubation with cell
monolayers. No significant difference was observed
between in vivo and in vitro matured oocytes (P > 0.05).
Experiment 6: Identification of oviductin, osteopontin and 
ANP A genes and proteins in equine species
Identification of genes in the equine genome
SPP1  gene encoding osteopontin was found in horse
genome as [RefSeq: XP_001496202]. The gene is known
by projection protein coding, but there are a lot of crossed
supporting evidences to show the veracity of this gene.
Moreover exons/introns prediction seems probable.
NPPA gene encoding ANP A was found in horse genome
as [Ensembl: ENSECAG00000014892]. The protein cod-
ing is known and a crossed supporting evidences of reality
of this gene is an alignment with [EMBL: X58563] horse
mRNA.
OVGP1  gene encoding oviductin was found in horse
genome as [Ensembl: ENSECAT00000024758]. The gene
is known by projection protein coding, and there are so
few crossed supporting evidences to validate the veracity
of this gene. Moreover exons/introns prediction seems
not probable because some introns of one base pair were
detected. No EST was found for this gene in horse Unigene
http://www.ncbi.nlm.nih.gov/UniGene/
UGOrg.cgi?TAXID=9796. The result of tblastn of cow ovi-
ductin vs horse genome is a match located on horse chro-
mosome 5 between WDR77 and C3H1orf88 genes. The
alignment shows the presence of stop codons. To under-
stand which event appears to create these stop codons, we
used genewise. Figure 3 shows the alignment of cow ovi-
ductin protein sequence vs the large corresponding horse
genomic sequence with a corrupted exon by a stop codon.
This stop codon is due to the absence on horse genomic
sequence of 5 nucleic base pairs in comparing with cow
genomic sequence (Figure 4). This absence induces a
frameshift and the coding of stop codon TAA. Thus, we
could suppose that horse OVGP1 gene might be either a
pseudogene or the result of sequencing error.
Evolutionary distance computation between horse pro-
teins predicted in databases (osteopontin, ANP A and ovi-
ductin) and respective orthologue proteins of cow, pig,
human and mouse is given in table 1. Evolutionary dis-
tance computing shows that horse and cow or human tar-
get proteins are not so far between them.
Identification of proteins in the equine oviduct fluid using surface 
plasmon resonance
We analyzed the presence of osteopontin and ANP A in
oviducts collected from mares of unknown oestrus cycle
stage using a surface plasmon resonance biosensor.
Surface plasmon resonance experiments showed that the
injection of a diluted oviduct fluid resulted in a binding to
the anti-osteopontin antibody surface (Figure 5A) and to
the anti-ANP A antibody surface (Figure 5B). These results
show that osteopontin and ANP A are present in the
equine oviduct fluid.
Expression of osteopontin and ANP A during the oestrus cycle in the 
equine oviduct fluid
We analyzed the expression of osteopontin and ANP A
using gel electrophoresis and immunoblotting in oviducts
collected from mares slaughtered 1) at the time of emer-
gence of the dominant follicle, 2) at the end of the follic-
ular growth, 3) at the preovulatory stage.
The antibody raised against osteopontin revealed a band
between 50 and 60 kDa in equine oviducts in the three
stages of the estrus cycle (Figure 5C). Moreover, the anti-
body raised against ANP A revealed a band between 15
and 20 kDa in equine oviducts in the three stages of the
estrus cycle (Figure 5D). Thus, the gel electrophoresis and
immunoblotting technique confirmed the expression of
osteopontin and ANP A in the equine oviduct. No obvi-
ous difference of the amount of osteopontin or ANP A was
observed between the three stages.
Checking for a potential expression of oviductin in the equine oviduct
The antibody raised against bovine oviductin did not
reveal any signal in equine oviducts (data not shown).
This could be due to the absence of oviductin or to the
lack of cross-reactivity between the antibody and the
equine oviductin. We previously checked that this anti-
body revealed a band at 97 kDa in the bovine oviduct.
Experiment 7: Influence of osteopontin and ANP A on 
equine IVF
After co-incubation of equine oocytes with or without
purified osteopontin, the IVF rates were not significantly
different between 0, 0.01 and 1 μg ml-1, between 0, 0.1
and 10 μg ml-1, or between 0, 50 and 100 μg ml-1 of oste-
opontin (P > 0.05; Figure 6A), albeit a slight increase with
10 μg ml-1 of osteopontin. Moreover, when the oocytes
were co-incubated with high doses of osteopontin (50
and 100 μg ml-1), lots of them degenerated, and thus were
not taken into account.Reproductive Biology and Endocrinology 2009, 7:129 http://www.rbej.com/content/7/1/129
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Alignment of cow oviductin with horse chromosome 5 DNA sequence Figure 3
Alignment of cow oviductin with horse chromosome 5 DNA sequence. The alignment shows the cow OVGP1 pro-
tein sequence on the first line. The second line indicates the similarity level of the match. The following 4 lines represent the 
DNA sequence of the part of horse chromosome 5 (location between 7883595-7903595 bp, strand +) where OVGP1 gene is 
predicted and its translation. The DNA sequence is presented with the exons descending in triplets, each triplet being a codon. 
The translation of each codon is shown above it. In introns the DNA sequence is not shown but for the first 7 bases making 
the 5' splice site and the last 3 bases of the 3' splice site. The intervening sequence is indicated in the square brackets. The pink 
exclamation point represents a sequence disruption.
ovgp1_bos         46 RFTTMLSTFSNRERFVSSVIALLRTHGFDGLDLFFLYPGLRGSPARDRW  
                     RFTT+LS  +N E F+ SV +LLRTH F GLDLFFLYPGLRGSP  D W  
                     RFTTVLSASANWEVFIDSVASLLRTHDFGGLDLFFLYPGLRGSPMHDWW  
7883595-7903595 4886 ataagctgtgatggtagtggtccaacgtggcgcttttcgcagacacgtt  
                     gtccttccccagatttactccttgcaatggtattttacgtgggctaagg  
                     gcctggtatccgggttcataccggatcctcgccccgctaaacccgccgg  
ovgp1_bos         95 TFVFLLE                       ELLQAFKNEAQLTMRPRLL  
                     TF+FL+E                       E        A+LT+RPRLL  
                     TFLFLIE                       E--------ARLTIRPRLL  
7883595-7903595 5033 atcttagGTAAGGC  Intron 1   AAGg        gccaaccacc  
                     cttttta<0-----[5054 : 5620]-0>a        cgtctgcgtt  
                     ttccata                       g        agccctaggg  
ovgp1_bos        121 LSAAVSGDPHVVQKAYEARLLG                          L  
                     LSAAVSGDP +VQ AY+A  LG                          L  
                     LSAAVSGDPDIVQTAYDACCLG           R:R[aga]       L  
7883595-7903595 5654 ctgggtggcgagcagtggttcgAGGTGAGTG  Intron 2   CAGAc  
                     tccctcgacattaccaacggtg  <2-----[5722 : 6989]-2> t  
                     ctttctgcacccaatttgctaa                          c  
ovgp1_bos        145 LDFISVLSYDLHGSWEKVTGHNSPLFSLPGDPKSS                
                     LDFISVLS DLHGSWEK+  HNSPLFSLPGD KS                 
                     LDFISVLSCDLHGSWEKI!-HNSPLFSLPGDSKSL                
7883595-7903595 6994 cgtaagtttgtcgatgaa1 caaccttccggtatt                
                     tattgttcgatagggaat  aagcttctcgacact                
                     gtcctcgttcatacgagc  tcccgctgtaccatg                
ovgp1_bos        180                        AYAMNYWRQLGVPPEKLLMGLPTYGR  
                                            AYAMN WR+LG PPEKLLMGLPTYGR  
                                            AYAMNSWRKLGAPPEKLLMGLPTYGR  
7883595-7903595 7094 GTAAGAA  Intron 3   CAGgtgaattcacggccgaccagccatgc  
                     <0-----[7094 : 7194]-0>cactacggatgcccaatttgtccagg  
                                            atcgtcgagtgacaggccggacctat  
ovgp1_bos        206 TFHLLKASQNELRAQAVGPASPGKYTKQAGFLAYYE               
                      F LL+AS+  L+A+AV PA PGKY KQAGFLAYYE               
                     PFRLLRASKTGLQAEAVEPAFPGKYIKQAGFLAYYE               
7883595-7903595 7273 ctcccagtaagccgggggcgtcgataacggttgttg               
                     ctgttgccacgtacactacctcgaataacgttcaaa               
                     ctcccacagtgggcatgacataggccgatccgtttg               
ovgp1_bos        242                        ICCFVRRAKKRWINDQYVPYAFKGKE  
                                            IC FV++ KKRWI+ QY+PYA+KGKE  
                                            ICYFVQKVKKRWIDYQYIPYAYKGKE  
7883595-7903595 7381 GTGACAG  Intron 4   CAGatttgcagaactagtctactgtagag  
                     <0-----[7381 : 8980]-0>tgattaataaggtaaaatcacaagaa  
                                            tcctcgagggcgtttgtcatccgggg  
ovgp1_bos        268 WVGYDDAISFGYK                       AFFIKREHFGGAM  
                     WVGYDDAISF YK                       A+FIKREHFGGAM  
                     WVGYDDAISFSYK                       ALFIKREHFGGAM  
7883595-7903595 9059 tggtgggaatataGTAAGAC  Intron 5   CAGgttaaagctggga  
                     gtgaaactgtgaa<0-----[9098 :12396]-0>ctttagaatggct  
                     gtctttcccctca                       agcagaattgtcg  
ovgp1_bos        294 VWTLDLDDFRGYFCGTGPFPLVHTLNNLLVND                   
                     VWTLDLDD RG F G GPF LV+ LN+LLV                     
                     VWTLDLDDVRGTFYGVGPFRLVYVLNHLLVQA                   
7883595-790359512436 gtacgcgggagattgggctccgtgtacccgcg                   
                     tgctataatggctagtgctgttattaatttac                   
                     ggagcgttcgctcttgctcctctggttcgagt                   
ovgp1_bos        326                           FSSTPSPKFWFSTAVNSSRIGPE  
                                               FSSTPSPKFW+S+A+NSS    E  
                               E:E[gag]        FSSTPSPKFWLSSAMNSSGTDSE  
7883595-790359512532 GGTAAGTA  Intron 6   TAGAGtatactcattcttgaattgagtg  
                      <1-----[12533:13509]-1>  tgcccccatgtccctaccgcaca  
                                               ccattaaatgcattgttaaccta  
ovgp1_bos        350 MPTMTRDLTTGLGILPPGGEAVATETHRKSETMTITPKGEIATPTRTPL  
                       T+T+ LTT LGIL P  EA+ATETHRKSE MT  P+G   TP R  +  
                     RLTVTKALTTDLGILSPREEAMATETHRKSENMTTIPRGGTVTPIRETM  
7883595-790359513581 acagaagtaagtgattcagggagagacaatgaaaaacaggagacaagaa  
                     gtctcactccatgttccgaactccacagacaatcctcgggctcctgact  
                     ggtgcgagcttggtgcagagtgctgctagtatgcaccatgtgctagatg  
ovgp1_bos        399 SFGRRTAA-----PEGKT                       -ESPGEKP  
                     SFG+ T A     P G +                         +PG     
                     SFGKSTVALEDHDPCGPS                       TVTPGGMT  
7883595-790359513728 ttgaaaggcggcgctgctGTCTGTG  Intron 7   TAGagacggaa  
                     ctgagctctaaaacggcc<0-----[13782:13827]-0>ctccggtc  
                     ctagctataactcctgaa                       tgctaagt  
ovgp1_bos        419 LTTVGHLAVSPGGIAVGPVRLQT---GQKVTPPGRKAGVPEKVTTPSGK  
                     LT VGH +V+P  + + P+ LQT   G+K+ P  RK    EK+T PSGK  
                     LTPVGHQSVTPAKMTITPMHLQTETPGEKIIPLRRKTVATEKMTIPSGK  
7883595-790359513852 tacggcctgacgaaaaacacccagacggaaaccaaaaggagaaaactga  
                     tcctgaactcccatctcctatacaccgaattctggactccaatctccga  
                     gctgttgtgctaggtcttgttatgctaggcactaggtactaggtcctag  
ovgp1_bos        465 MTVTPDGR                                           
                     MTVTP GR                                           
                     MTVTPMGR                                           
7883595-790359513999 aagacaga                                           
                     tctcctgg                                           
                     gaccagca                                           Reproductive Biology and Endocrinology 2009, 7:129 http://www.rbej.com/content/7/1/129
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After co-incubation of equine oocytes with or without
synthesized ANP A, the IVF rates were not significantly dif-
ferent between 0, 1 and 10 nmol l-1 of ANP A, or between
0, 0.1 and 50 nmol l-1 of ANP A (P > 0.05; Figure 6B).
Discussion
In mammals, the oviduct epithelial cells and oviduct
secretory products facilitate gametes transport and matu-
ration, fertilization and early embryo development [1].
Our first objective was to verify the beneficial effect of the
oviduct cells and fluid on the equine in vitro fertilization
(IVF). Our results show that the co-culture of oviduct epi-
thelial cells with equine gametes increased the IVF rate.
In our conditions, the IVF rate was higher for equine gam-
etes co-incubated with porcine vesicles than without ovi-
duct cells. In addition, after co-incubation of equine
gametes with oviduct cells, the IVF rate was not different
between porcine and equine oviduct cells. The beneficial
effect of homologous oviduct cells on in vitro production
of embryos is also demonstrated in human [5,6], bovine
[7-9], porcine [10,11], deer [12,13] and dromedary [14]
species. Several studies show a positive effect of heterolo-
gous oviduct cells on gametes, fertilization and embryo
development. For example, the development of deer
embryos is improved in sheep oviduct [12] or with ovine
oviduct epithelial cells in culture [13]. Isolated mouse ovi-
duct is capable of supporting development of bovine
embryos [60]. Similar numbers of canine or human sper-
matozoa bind to heterologous or homologous oviducts
and the capacitating responses are not different between
homologous and heterologous oviducts [61,62]. In our
study, we collected equine and porcine oviducts from 4 to
6 hours after ovulation. In vivo, fertilization has been
shown to occur during this period in equine or porcine
species [63,64]. Moreover, porcine oviduct cells have a
better competence to support porcine embryo develop-
ment when they are collected at ovulation or corpus
luteum stages than at other ovarian cyclic stages [65].
Thus, we used oviduct cells collected during the in vivo fer-
tilization period to keep the favourable environment of
fertilization.
In our study, equine oocytes were co-incubated with ovi-
duct cells for 2 to 3 hours before IVF. Indeed, equine IVF
rates increase when oocytes are collected from the oviduct
compared to preovulatory oocytes [24,63] or when preo-
vulatory oocytes are pre-incubated in the fertilization
medium before gametes co-incubation [24]. In bovine
and porcine species, the co-culture of oocytes with oviduct
cells before gametes co-incubation, improves the IVF rates
[15] and promotes the association of oviductal proteins
with the zona pellucida [66-68]. In addition, during the
co-culture of porcine oocytes with porcine oviduct cells,
the structure of the zona pellucida is modified [[69] for
review] and the cortical granules migrates near the cortex
[70,71]. The co-incubation of oocytes with oviduct cells
may have a positive effect on their competence for fertili-
zation. Further studies would be necessary to clarify the
Alignment of cow OVGP1 DNA region and horse chromosome 5 DNA sequence Figure 4
Alignment of cow OVGP1 DNA region and horse chromosome 5 DNA sequence. Extract of result of blastn 
between OVGP1 DNA regions on chromosome 3 and chromosome 5 respectively from cow and horse. Star represents stop 
codon provoked by absence on horse genome of five nucleic bases highlighted in grey on cow genome. Dashed lines corre-
spond to mismatches.
Table 1: Evolutionary distances between horse proteins 
predicted in databases and orthologue proteins of cow, pig, 
human and mouse
Cow Pig Human Mouse
osteopontin_horse 0.391 0.332 0.283 0.451
ANP-A_horse 0.154 0.138 0.154 0.233
oviductin_horse 0.403 0.388 0.337 0.516
The number of amino acid substitutions per site from analysis 
between sequences is shown between osteopontin, ANP A and 
oviductin horse proteins and their orthologues of cow, pig, human 
and mouse. All results per protein are based on the pairwise analysis 
of 5 sequences. Analyses were conducted using the JTT matrix-based 
method in MEGA4. All positions containing gaps and missing data 
were eliminated from the dataset.Reproductive Biology and Endocrinology 2009, 7:129 http://www.rbej.com/content/7/1/129
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interaction between equine oocytes and oviduct secre-
tions.
In our conditions, the equine IVF rate with oviduct cells
was low. We hypothesized that most of the equine in vitro
matured oocytes may not be competent for fertilization.
However, equine in vitro matured oocytes can undergo in
vivo fertilization after intraoviductal transfer like in vivo
matured oocytes [45,46]. Moreover, we analyzed the
influence of oviduct cells on the IVF of in vivo matured
oocytes. Our results showed that the presence of oviduct
cells did not improve the IVF of equine in vivo matured
oocytes. After co-incubation with oviduct cells, the IVF
rate was not different between in vivo and in vitro matured
oocytes. Thus, our low IVF rate may not be due to a low
competence of in vitro matured oocytes.
Then, we hypothesized that the removal of cumulus cells
had decreased the IVF rates. Indeed, in the pig, the absence
of cumulus cells significantly decreases the IVF rates with
or without oviduct cells [72-74]. In cattle, the absence of
cumulus cells decreases the number of blastocysts in pres-
ence or absence of oviduct cells [75,76]. In equine species,
most IVF techniques use oocytes without cumulus cells
[25-27], but to our knowledge, no comparison of
denuded and intact oocytes have been published. Our
results showed that, in our conditions, the equine IVF rate
was not different between oocytes with or without cumu-
lus cells. Thus, the absence of cumulus cells doesn't
appear to be responsible for our low in vitro fertilization
rate. In equine species, the cumulus cells could not be
essential for in vitro fertilization unlike in porcine or
bovine species. However, further studies would be neces-
sary to clarify this point.
We further postulated that the secretions from oviduct
cells in culture were not optimal in our conditions. In por-
cine species, the oviductal secretory proteins are under
oestrogen and LH control [23,77]. Thus, we co-incubated
equine gametes with porcine oviduct cells previously
stimulated with 1 μg ml-1 of E2, 0.1 μg ml-1 of porcine LH,
150 mIU ml-1 of hCG or LH and E2. Our results showed
that the hormonal stimulation of porcine oviduct cells
had no beneficial effect on equine IVF.
The co-culture of porcine gametes with oviduct cells pre-
viously stimulated for 48 hours with 1 μg ml-1 of E2 signif-
icantly increase the cleavage rate [78]. Although we used
the same dose of E2, the hormonal stimulation may have
been too short (24 hours) in our conditions. It has been
reported that the stimulation of bovine oviduct cells with
150 mIU ml-1 of hCG increase the oviductal glycoprotein
secretion [79] and the percentage of bovine blastocyst
[80]. Our results suggest that hCG may be inefficient on
porcine oviduct cells, but further studies are necessary to
clarify this point. In porcine species, 100 ng ml-1 of LH has
been shown to be efficient to induce relaxation of the ovi-
duct [81], but, in our conditions, it could be inefficient for
stimulation of porcine oviduct secretions.
Then, we postulated that the co-stimulation of E2 and LH
could increase the porcine oviductal secretion. In porcine
species, E2 increases the quantity of LH receptors in cili-
ated cells [82]. However, in our conditions, this co-stimu-
lation did not have any effect on the IVF rate, and thus
probably on the secretions of porcine oviduct cells in cul-
ture. In this study, due to the low number of equine
oocytes available, only one concentration was tested for
each hormone, according to the efficient concentrations
published in the literature. This concentration could not
be the efficient one to stimulate porcine oviductal secre-
tions. Different combinations of hormone concentrations
should ideally be investigated to evaluate the effect of E2,
LH and hCG on porcine oviduct secretions.
Surface plasmon resonance binding and Western blot data Figure 5
Surface plasmon resonance binding and Western 
blot data. Surface plasmon resonance binding data (A, B): 
oviduct fluid diluted 1/25 was injected on anti-osteopontin 
antibody (A) or anti- ANP A antibody (B) surface. The sen-
sorgramms show an association phase (increasing response) 
during the 120 seconds injection of fluid, followed by a disso-
ciation phase (decreasing response) studied for 120 seconds. 
Shown sensorgramms have been subtracted from the sen-
sorgramms obtained on their reference surface. Western 
blot data (C, D): Osteopontin (C) and ANP A (D) protein 
expression in equine oviducts from stage 1 (emergence of 
the dominant follicle, lane 1), stage 2 (end of the follicular 
growth, lane 2) and stage 3 (preovulatory stage, lane 3).
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Finally, the limited number of equine oocytes available
for studies did not allow us to test different sperm prepa-
rations. We used fresh equine semen treated with calcium
ionophore A23187 because this treatment previously
allowed equine IVF [24] in a repeatable way [83,26,45].
However, other sperm preparations should be tested, that
use fresh or frozen semen treated with calcium ionophore
or heparin [25,26]. Recently, a new IVF technique based
on sperm hyperactivation has been published [27] but
unfortunately, up to now, we are not able to obtain high
IVF rates with this technique. The potential reasons for the
low IVF rate in the horse are difficult to identify, due to the
rather low number of conditions that have been tested,
and the low number of oocytes used in each experiment.
Influence of osteopontin and ANP A on equine IVF Figure 6
Influence of osteopontin and ANP A on equine IVF. In vitro fertilization rates (IVF, percentage of fertilized oocytes per 
matured oocytes) of equine gametes. A) Gametes co-incubated with or without bovine osteopontin; in each trial, the IVF rates 
were not significantly different between the three concentrations (P > 0.05); B) Gametes co-incubated with or without bovine 
ANP A; in each trial, the IVF rates were not significantly different between the three concentrations (P > 0.05); The fractions 
represent the number of fertilized oocytes out of matured oocytes (oocytes in metaphase II, activated and fertilized).
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Our second aim was to identify the proteins from the ovi-
duct involved in fertilization in the horse. Our study sug-
gests that the molecules secreted by equine or porcine
oviduct cells have a positive effect on the equine IVF rate.
In porcine, bovine and human species, osteopontin, ovi-
ductin and ANP A, which are secreted in oviduct fluid,
increase the IVF rates and improve the early embryo devel-
opment [9,10,17,21-23,84,85]. We postulated that these
molecules could have a positive effect on the equine IVF.
In our study, we showed that OVGP1 gene encoding ovi-
ductin has a stop codon in equine genome. Moreover, we
were not able to show the expression of oviductin in
equine oviduct by Western blot. This could be due either
to the absence of oviductin or to the lack of cross-reactiv-
ity between the antibody and the equine oviductin despite
a weak evolutionary distance between equine and bovine
oviductin. Subsequently, on the one hand, we might sup-
pose that OVGP1 is a pseudogene, i.e. a gene that has
accumulated mutations during time and is become inac-
tive, as previously described in the rat [86]. On the other
hand, this stop codon is maybe due to sequencing error,
engendering a frameshift. In the case where we suppose
that OVGP1 is a pseudogene, we might suppose that, con-
versely to what has been described in human, bovine and
porcine species [9,10,23], oviductin may not be involved
in the mechanism of fertilization in the equine. However,
oviductin belongs to the mammalian family of chitinase-
like proteins [23,87]. We could hypothesise that one or
more other chitinases could be present in equine oviduct
fluid and involved in equine fertilization. Further studies
would be necessary to clarify this point.
We found the gene encoding osteopontin in equine
genome and confirmed its expression in the equine ovi-
duct fluid throughout follicle growth and maturation.
Thus, equine oviduct cells secrete osteopontin like por-
cine, human and bovine oviduct cells [17,84,85]. Our
results showed a slight increase of equine IVF rate with 10
μg ml-1 bovine osteopontin although it was not signifi-
cant. In bovine species, the co-incubation of spermatozoa
and oocytes with 10 μg ml-1 bovine osteopontin before
IVF increases the fertilization and cleavage rates [18,19].
In pigs, supplementation of the IVF medium with 0.1 μg
ml-1 rat osteopontin increases the cleavage rates and the
percentage of blastocysts [17]. Although we tested a wide
range of concentration of bovine osteopontin, no signifi-
cant effect on equine IVF rates was observed. It could be
suggested that despite a weak evolutionary distance
between equine and bovine osteopontin, bovine oste-
opontin is too divergent and could not interact with
equine gametes.
We found the gene encoding ANP A in equine genome
and confirmed its expression in the equine oviduct fluid
throughout follicle growth and maturation. In cattle, pig
and human, ANP A is also present in the oviduct
[21,22,88]. Despite a weak evolutionary distance between
equine and human ANP A, the presence of human ANP A
with equine gametes did not improve the IVF rates. Nev-
ertheless, human ANP A can have an effect on heterolo-
gous cells since 1 nmol l-1 of human ANP A improve the
IVF in porcine species [22]. In human, porcine and bovine
species, 1 or 10 nmol l-1 of human or rat ANP A incubated
with spermatozoa improve the acrosome reaction of sper-
matozoa [21,22,89]. We could hypothesize that human
ANP A did not interact with equine gametes in our condi-
tions, or that the concentration of ANP A was not efficient.
Due to the limited number of equine oocytes available for
studies, few conditions were tested in our experiments.
Further studies would be necessary to test osteopontin
and ANP from other species, other concentrations, sperm
preparations and IVF conditions.
Finally, the oviduct fluid contains many proteins and
some of them have been identified in pig and cattle [90-
93]. The proteins that are involved in equine IVF may be
different from osteopontin and ANP A, and several candi-
dates have to be tested. Moreover, osteopontin and ANP
A could be involved in fertilization through interactions
with other oviductal proteins to facilitate sperm-oocyte
interaction. Further experiments would be necessary to
characterize the proteins from equine oviduct and study
their role in equine IVF.
Our study showed that the surface plasmon resonance
technique is a new and efficient method to detect mole-
cules secreted by oviduct epithelial cells. This technology
allows qualitative analysis of complex fluid, measurement
of analyte concentration, and determination of affinity of
molecular interaction in real time, without the need for a
molecular tag or label [94,95]. It appears to be a sensitive
and powerful tool to study the molecules and the molec-
ular interactions involved in the mechanism of fertiliza-
tion.
Conclusion
In conclusion, our study reports beneficial effects of
equine or porcine oviduct epithelial cells co-culture on
equine IVF rates even if these remain low. We showed that
OVGP1 is maybe a pseudogene in equine genome, and
that osteopontin and ANP A are expressed in the equine
oviduct. The role of these molecules remains under ques-
tion, and further studies are in process to clarify this point.
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